Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
Introduction: Dysregulated genes play a critical role in the development and progression of cancer, suggesting their potential as novel independent biomarkers for cancer diagnosis and prognosis. Prognostic model-based gene expression profiles are not widely utilized in clinical medicine. We investig...
Main Authors: | Jian-Guo Zhou, Hua Zhong, Juan Zhang, Su-Han Jin, Raheleh Roudi, Hu Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00078/full |
Similar Items
-
Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
by: Jordi Guzmán‐Casta, et al.
Published: (2021-04-01) -
Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients
by: Yiyang Bai, et al.
Published: (2020-08-01) -
External validation of prognostic indices for overall survival of malignant pleural mesothelioma
by: Kataoka, Yuki
Published: (2020) -
Management of Pleural Effusion Secondary to Malignant Mesothelioma
by: Valeria Musso, et al.
Published: (2021-09-01) -
Expression of FGFR1–4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity
by: Gregor Vlacic, et al.
Published: (2019-09-01)